Experimental group:Bacteroides fragilis BF839

2 trials

Sponsors

Shenzhen Children's Hospital, The Second Affiliated Hospital of Guangzhou Medical University

Conditions

EpilepsyPsoriasis

Early Phase 1

Evaluation of safety and efficacy of Bacteroides fragilis BF839 in the adjuvant treatment of refractory epilepsy in children

RecruitingChiCTR2100042203

Shenzhen Children's HospitalEpilepsy

Start: 2021-02-01Updated: 2021-04-19

Efficacy of bacteroides fragilis BF839 in the adjunct treatment of mild to moderate psoriasis vulgaris: a single-center, randomized, double-blind, parallel controlled clinical trial

RecruitingChiCTR2100054919

The Second Affiliated Hospital of Guangzhou Medical UniversityPsoriasis

Start: 2022-01-01Updated: 2022-12-12